The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

The FDA has approved Janssen’s antidepressant nasal ... the drug home. The drug is also being reviewed by the EMA, which is looking to make a decision later this year or early 2020. “Spravato ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression ... report on Spravato (esketamine) and says the drug would need to be between 25% and 52% cheaper ...

Amid current economic uncertainties, investing in defensive stocks appears as your best bet for stability, especially if a ...

Each of the RSU grants vests ratably in equal installments on the first, second, and third anniversaries of the grant date, subject to the recipient's continued service with the Company through the ...

Investing in dividend aristocrats can form the cornerstone of a reliable investment strategy, owing to their qualities like ...

After hours: February 7 at 7:59:30 PM EST Loading Chart for JNJ ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

The biotech industry’s DeepSeek moment came last fall.

After hours: February 7 at 7:33:12 PM EST Loading Chart for DRUG ...

Emerging research has linked heavy cannabis use to multiple health risks, including stroke and heart attack. Now, a new study suggests that frequent use of cannabis may also damage the brain’s working ...

Nanocarriers are promising in tumour-targeting drug delivery but limited by their delivery efficiency within tumour microenvironment (TME). Here the authors report the development of lipoic acid ...